Bausch Health (BHC) Companies announced that Health Canada has granted medical device license clearance for Thermage FLX, the latest generation of the globally-recognized Thermage system for non-invasive skin tightening and contouring. Thermage FLX represents the fourth generation of innovation in monopolar radiofrequency technology from Solta Medical. With a long legacy of trust among providers and patients, the Thermage platform is a globally established system trusted by providers for more than 20 years. In Canada, providers have eagerly awaited the next evolution of this system, and they will now gain access to the same smart technology already in use by leading aesthetic clinics around the world.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC:
- Bausch Health Companies (BHC) Q1 Earnings Cheat Sheet
- Bausch Health announces launch of Solta Medical’s Fraxel FTX
- Bausch Health Addresses Icahn’s Equity Swaps and Adopts Shareholder Rights Plan
- Bausch Health announces filing of supplement to proxy statement
- Bausch Health price target lowered to $5 from $7 at BofA
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue